Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Frontiers in Cardiovascular Medicine|September 12, 2022
Growth differentiation factor-15 as a biomarker of atherosclerotic coronary plaque: Value in people living with and without HIVLéna Royston, Stéphane Isnard, Nils Perrin, et al.
Open Forum Infectious Diseases|March 30, 2022
Long-Term Efficacy, Safety, and Durability of Cabotegravir and Rilpivirine as 2-Drug Oral Maintenance Therapy After 6 Years of StudyKenneth C Sutton, Jerome De Vente, Roger Leblanc, et al.
Plos One|June 26, 2014
Kinetics of HIV-1 CTL epitopes recognized by HLA I alleles in HIV-infected individuals at times near primary infection: the Provir/Latitude45 studyJennifer Papuchon, Patricia Pinson, Gwenda-Line Guidicelli, et al.
Plos One|October 9, 2014
A significant reduction in the frequency of HIV-1 drug resistance in Québec from 2001 to 2011 is associated with a decrease in the monitored viral loadHugues Charest, Florence Doualla-Bell, Régis Cantin, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|September 4, 2012
Management and treatment of hepatitis B virus in patients with HIV infection: A practical guide for health care professionalsMarina B Klein, Jean-Guy Baril, Marc-André Charron, et al.
The Journal of Infectious Diseases|March 29, 2002
Human immunodeficiency virus (HIV)-specific effector CD8 T cell activity in patients with primary HIV infectionGalit Alter, Alefia Merchant, Christos M Tsoukas, et al.
Journal of the International AIDS Society|February 8, 2018
Socio-economic status and time trends associated with early ART initiation following primary HIV infection in Montreal, Canada: 1996 to 2015Vikram Mehraj, Joseph Cox, Bertrand Lebouché, et al.
Viruses|August 29, 2024
Phylogenetic Network Analyses Reveal the Influence of Transmission Clustering on the Spread of HIV Drug Resistance in Quebec from 2002 to 2022Bluma G Brenner, Ruxandra-Ilinca Ibanescu, Maureen Oliveira, et al.
The Journal of Infectious Diseases|March 3, 2007
High rates of forward transmission events after acute/early HIV-1 infectionBluma G Brenner, Michel Roger, Jean-Pierre Routy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 8, 2022
Association Between the Development of Subclinical Cardiovascular Disease and Human Immunodeficiency Virus (HIV) Reservoir Markers in People With HIV on Suppressive Antiretroviral TherapyIsabelle Turcotte, Mohamed El-Far, Manel Sadouni, et al.
Pageof 7